PD-1-IN-17 TFA is a programmed cell death-1 (PD-1) inhibitor extracted from patent WO2015033301A1, Compound 12, inhibits 92% splenocyte proliferation at 100 nM.

Product information

Molecular Weight: 488.37

Formula: C15H23F3N6O9

Chemical Name: (2S)-2-({[(1S)-1-{5-[(1S,2R)-1-amino-2-hydroxypropyl]-1,3,4-oxadiazol-2-yl}-3-carbamoylpropyl]carbamoyl}amino)-3-hydroxypropanoic acid; trifluoroacetic acid

Smiles: C[C@@H](O)[C@H](N)C1=NN=C(O1)[C@H](CCC(N)=O)NC(=O)N[C@@H](CO)C(O)=O.OC(=O)C(F)(F)F

InChiKey: PYCIDBUEUQEHMB-UGQQCFMUSA-N

InChi: InChI=1S/C13H22N6O7.C2HF3O2/c1-5(21)9(15)11-19-18-10(26-11)6(2-3-8(14)22)16-13(25)17-7(4-20)12(23)24;3-2(4,5)1(6)7/h5-7,9,20-21H,2-4,15H2,1H3,(H2,14,22)(H,23,24)(H2,16,17,25);(H,6,7)/t5-,6+,7+,9+;/m1./s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

Products are for research use only. Not for human use.